Kindly MD, Inc. (NASDAQ:KDLY) Short Interest Up 1,222.6% in February

Kindly MD, Inc. (NASDAQ:KDLYGet Free Report) was the recipient of a large growth in short interest in the month of February. As of February 15th, there was short interest totalling 638,800 shares, a growth of 1,222.6% from the January 31st total of 48,300 shares. Based on an average trading volume of 4,370,000 shares, the short-interest ratio is currently 0.1 days. Currently, 33.1% of the company’s stock are sold short.

Kindly MD Trading Up 0.3 %

Shares of NASDAQ KDLY traded up $0.01 during mid-day trading on Thursday, hitting $1.93. 69,874 shares of the stock traded hands, compared to its average volume of 6,914,818. The stock has a fifty day moving average price of $1.60 and a 200-day moving average price of $1.36. Kindly MD has a 52 week low of $0.65 and a 52 week high of $5.25.

Institutional Trading of Kindly MD

A number of hedge funds have recently modified their holdings of the business. Ground Swell Capital LLC purchased a new position in Kindly MD during the 4th quarter valued at about $28,000. Cetera Investment Advisers purchased a new position in shares of Kindly MD during the fourth quarter valued at approximately $93,000. Finally, Townsquare Capital LLC bought a new stake in shares of Kindly MD in the 3rd quarter worth approximately $736,000.

Kindly MD Company Profile

(Get Free Report)

Kindly MD, Inc provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Recommended Stories

Receive News & Ratings for Kindly MD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindly MD and related companies with MarketBeat.com's FREE daily email newsletter.